Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sofia Westbom Fremer"'
Autor:
Maria Bååth, Sofia Westbom-Fremer, Laura Martin de la Fuente, Anna Ebbesson, Juliette Davis, Susanne Malander, Anna Måsbäck, Päivi Kannisto, Ingrid Hedenfalk
Publikováno v:
Molecular & Cellular Oncology, Vol 7, Iss 6 (2020)
The transcription factor SOX2 is a well-established and important stem cell marker. Its role in cancer biology remains unclear, but it has been proposed to also be a marker of cancer stem cells. We investigated the role of SOX2 protein expression in
Externí odkaz:
https://doaj.org/article/6bd8032c7fe94d93b758c4fa7e5ea4fa
Autor:
Sandra Wessman, Beatriz Bohorquez Fuentes, Josefin Severin-Karlsson, Sofia Westbom-Fremer, Monica Nistér, Georgia Kokaraki, Tirzah Braz Petta, Felix Haglund, Joseph W. Carlson
Publikováno v:
International Journal of Gynecological Pathology.
Autor:
Brooke E. Howitt, Emily E. Meserve, Loes F. S. Kooreman, Britta Weigelt, Sabrina Croce, Sofia Westbom-Fremer, Mona El-Bahrawy, Gian Franco Zannoni, Pankhuri Wanjari, Eduardo Benzi, Thomas Krausz, Jennifer A. Bennett, Arnaud Da Cruz Paula, Esther Oliva, Lauren L. Ritterhouse, Ninad M Patil, Chaojie Zhen, Robert H. Young, J. Kenneth Schoolmeester, W. Glenn McCluggage
Publikováno v:
Am J Surg Pathol
American Journal of Surgical Pathology, 45(8), 1061-1074. LIPPINCOTT WILLIAMS & WILKINS
American Journal of Surgical Pathology, 45(8), 1061-1074. LIPPINCOTT WILLIAMS & WILKINS
We describe 22 examples of a novel, usually paratubal, adnexal tumor associated with Peutz-Jeghers syndrome in nearly 50% of cases that harbored STK11 alterations in all tested (n=21). The patients ranged from 17 to 66 (median 39) years and the tumor
Autor:
Nicolai Skovbjerg Arildsen, Jenny-Maria Jönsson, Katarina Bartuma, Anna Ebbesson, Sofia Westbom-Fremer, Anna Måsbäck, Susanne Malander, Mef Nilbert, Ingrid A. Hedenfalk
Publikováno v:
Frontiers in Oncology, Vol 7 (2017)
ObjectiveOvarian clear cell carcinomas (OCCCs) constitute a rare ovarian cancer subtype with distinct clinical features, but may nonetheless be difficult to distinguish morphologically from other subtypes. There is limited knowledge of genetic events
Externí odkaz:
https://doaj.org/article/07791a094ade4600acdf89a8b1810bfb
Autor:
Arne Östman, Joseph W. Carlson, Artur Mezheyeuski, Charlotte Rolny, Susanne Malander, Sara Corvigno, Sofia Westbom-Fremer, Hanna Dahlstrand, Päivi Kannisto, Josefin Fernebro, Ingrid Hedenfalk, Laura Martin de la Fuente, Elisabeth Åvall-Lundqvist
Publikováno v:
Gynecologic Oncology. 159:860-868
Objective Pre-clinical studies have identified marker- and tumor compartment-defined functionally distinct macrophage subsets. Our study analyzes marker-defined macrophage subsets in different tumor compartments of high-grade serous ovarian cancer (H
Autor:
Maria Bååth, Jenny-Maria Jönsson, Sofia Westbom Fremer, Laura Martín de la Fuente, Lena Tran, Susanne Malander, Päivi Kannisto, Anna Måsbäck, Gabriella Honeth, Ingrid Hedenfalk
Publikováno v:
Genes
Volume 12
Issue 5
Genes, Vol 12, Iss 742, p 742 (2021)
Volume 12
Issue 5
Genes, Vol 12, Iss 742, p 742 (2021)
Overexpression of the receptor tyrosine kinase MET has been linked to poor survival in several cancer types, and MET has been suggested to interact with stem cell networks. In vitro studies have further suggested a possible benefit of a combined trea
Autor:
Dijana Djureinovic, Patrick Micke, Martin Isaksson-Mettävainio, Hans Brunnström, Anna Johansson, Max Backman, Sofia Westbom-Fremer, Annika Patthey, Miklos Gulyas
Publikováno v:
Modern Pathology. 30:1411-1421
Assessment of programmed cell death ligand 1 (PD-L1) immunohistochemical staining is used for decision on treatment with programmed cell death 1 and PD-L1 checkpoint inhibitors in lung adenocarcinomas and squamous cell carcinomas. This study aimed to
Autor:
Anna Måsbäck, Jonas Selling, Mehran Ghaderi, Tone Skeie-Jensen, Joseph W. Carlson, Ben Davidson, Sofia Westbom-Fremer, Elizabeth H. Cheek, Sofia Josefson, John K. Schoolmeester, Elin Hardell, Debra A. Bell
Publikováno v:
American Journal of Surgical Pathology. 41:1231-1237
Undifferentiated uterine sarcomas (UUS) are a heterogenous group of high-grade mesenchymal tumors. Although these tumors are highly aggressive, a subset of patients may experience long-term survival. These tumors have previously been divided morpholo
Autor:
Laura Martin de la Fuente, Sofia Westbom-Fremer, Susanne Malander, Linda Werner Hartman, Ingrid Hedenfalk, Anna Måsbäck, Päivi Kannisto, Nicolai Skovbjerg Arildsen
Publikováno v:
Virchows Archiv
The response rate to checkpoint inhibitors for women with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum (HGSC) is modest, and development of predictive biomarkers is needed. The main focus has been on tumor cell PD-L1 expre
Autor:
Jenny-Maria Jönsson, Anna Ebbesson, Anna Måsbäck, Susanne Malander, Nicolai Skovbjerg Arildsen, Mef Nilbert, Ingrid Hedenfalk, Sofia Westbom-Fremer
Publikováno v:
Clinical Cancer Research. 22:B12-B12
Objective: Ovarian clear cell carcinomas (OCCCs) constitute a rare ovarian cancer subtype. Despite relatively clear clinical features, OCCCs can be difficult to distinguish morphologically from other epithelial ovarian cancers. OCCC gene expression s